ALIVUS / FY26 summary

The year in one view.

Alivus Life Sciences · annual summary assembled from the available FY26 source records.

Research layer active

Revenue across quarters

1,950

₹ Cr where applicable

PAT across quarters

443

₹ Cr where applicable

Source quarters

3

₹ Cr where applicable

EBITDA (₹ Cr)PositiveWatchNegative
3 actual records
Actual quarterly EBITDA (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q2 FY26: 194 · Positive source sentiment · 2025-10-30Q2 FY26Q3 FY26: 245 · Positive source sentiment · 2026-01-15Q3 FY26Q4 FY26: 237 · Positive source sentiment · 2026-04-??Q4 FY26245194
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.